The longest surviving beneficiary of Max’s programs in Fiji.

The longest surviving beneficiary of Max’s programs in Fiji.

Radha Bai Chandra is a 62-year-old widow, a mother, and the longest-surviving beneficiary of Max’s programs in Fiji. Although her search for treatment was long and challenging, the second life she now has from that search is worth it. In 2005, Radha Bai noted a change in her energy levels. She was usually an active person. She started to need longer naps and couldn’t complete everyday chores. At this time, she lost a lot of weight. Her husband and 11-year-old daughter also noticed she was more tired than usual. A neighbor helped her to be seen in the hospital, and after many tests, she was told she had a ‘Blood Disorder.’ Somehow she managed to travel to Auckland, New Zealand, where she was diagnosed with Chronic Myeloid Leukemia. Unfortunately, her treatment plans were too expensive, and she returned to Fiji with only a few months’ supply of medication.

In 2006 Radha Bai faced a dwindling supply of medication and no health insurance. During this time, she lost her husband to a sudden illness. Without warning, Radha Bai was a new widow and a single mother with Leukemia. She made the tough decision to send her daughter to live with her brother in New Zealand.

Her Doctor in New Zealand did not give up and found a Max contact. After communication back and forth with paperwork, tests, and prayers, she was approved to get treatment through Max. In her own words: “The Max Foundation gave me the gift of a second life” Radha Bai is looking forward to traveling in October 2022 to attend her daughter’s wedding in New Zealand.

Radha Bai complies with her treatment requirement; she is punctual at the clinics and responsive to her doctor’s instructions. Besides her occupation helping with domestic duties, she is a powerful advocate of good health to her friends, relatives, and community. Her advice to patients who live with CML: “Live a healthy lifestyle, obey your doctors, ensure your medication is stored well, and be compliant!

For the 16 years living with Leukemia, Radha Bai’s message to all of us at The Max Foundation: “VINAKA VAKALEVU (Thank you) for saving me and the second life you have given me through the free medication.

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • Support Diagnostic Testing for Cancer Patients With A Cup of Chai

    Support Diagnostic Testing for Cancer Patients With A Cup of Chai

    When he was initially diagnosed with chronic myeloid leukemia, Prashant’s first concerns weren’t whether he would be able to afford treatment, it was about how much time he had left…years? Months? Would he be able to complete his degree? Would he be able to care for his father?

    But his doctor reassured him. Treatment was available, and before he could worry about the cost of it, Prashant was connected with The Max Foundation and worked on getting enrolled in the access program we administer.

  • The Max Foundation Joins Poptivism

    The Max Foundation Joins Poptivism

    The Max Foundation is joining Poptivism — a consumer-driven charitable giving program that sells unique PopSocket Grips and donates 50% of the sales of those PopGrips to support a nonprofit’s mission (that’s us!). Please consider purchasing one of our Poptivism PopGrips today! With each purchase, you’ll help expand access to lifesaving cancer treatment the world over.

  • The GIPAP Program Detailed in the ASCO Journal of Global Oncology

    The GIPAP Program Detailed in the ASCO Journal of Global Oncology

    Last week ASCO launched the inaugural issue of the Journal of Global Oncology. This new open access, online journal focuses exclusively on cancer research, treatment, and the delivery of care in middle and low resource countries.

    Among the first seven articles, published on September 23rd, are original research, commentaries, and review articles, including a special article looking at the Glivec International Patient Assistance Program (GIPAP), authored by our CEO Pat Garcia-Gonzalez, MS, and others.